A special supplement to the Journal of Alzheimer's Disease presents insights and new directions in both basic and clinical research into neurodegenerative diseases. Because by 2050, the number of people suffering from brain ...
Sep 28, 2023
0
25
Psilocybin, the active ingredient in psychedelic mushrooms, shows promise for the transitional treatment of episodic migraines in early clinical trials, according to a review from Yale School of Medicine's Emmanuelle Schindler, ...
Aug 9, 2023
0
4
After attacking a tumor with a targeted therapy, the cancer might stagger but often comes back fighting—usually even harder to defeat. University of Saskatchewan (USask)-led research has revealed a promising strategy to ...
Mar 29, 2023
0
27
For patients with recalcitrant alopecia areata totalis or universalis, methotrexate combined with prednisone yields complete hair regrowth in about 31 percent of patients, according to a study published online March 8 in ...
Mar 15, 2023
0
5
Researchers at The University of Texas MD Anderson Cancer Center have identified CD70 as being highly expressed on drug-resistant cancer cells in EGFR-mutant non-small cell lung cancer (NSCLC), highlighting a novel therapeutic ...
Feb 13, 2023
0
38
A few days ago, the Australian drug regulator—the Therapeutic Goods Administration (TGA)—surprised experts around the world when it announced the approval of certain psychedelic treatments.
Feb 8, 2023
0
1
Australia's drugs watchdog on Friday announced that psychedelic substances MDMA and psilocybin—more commonly known as ecstasy and magic mushrooms—will soon be used in the treatment of depression and post-traumatic stress.
Feb 3, 2023
0
24
Patient-reported outcomes from individuals diagnosed with relapsed or refractory large B-cell lymphoma revealed that those who received axicabtagene ciloleucel (axi-cel) immunotherapy experienced higher quality of life than ...
Jan 4, 2023
0
10
Recent evidence has emerged to suggest that age-related macular degeneration (AMD) is a clinical risk factor for increased risk for infection and mortality. AMD has been reported to confer higher risk of severe complications ...
Jan 3, 2023
0
32
Researchers at The University of Texas MD Anderson Cancer Center have discovered a novel immunotherapy combination, targeting checkpoints in both T cells and myeloid suppressor cells, that successfully reprogrammed the tumor ...
Dec 30, 2022
0
124
